Atypical hemolytic uremic syndrome (aHUS) is an extremely rare, life-threatening, progressive disease that frequently has a genetic component. In most cases it is caused by chronic, uncontrolled activation of the complement system, a branch of the body. Atypical hemolytic uremic syndrome panel is a molecular diagnostic test that screens for CFH, CFHR3, CFHR1, CFHR2, CD46, and CFI genes.
Call : 1800-102-4595
write to : firstname.lastname@example.org